Cite

HARVARD Citation

    Singh, V. et al. (2022). A dose‐escalation clinical trial of intranasal ketamine for uncontrolled cancer‐related pain. Pharmacotherapy. 42 (4), pp. 298-310. [Online]. 
  
Back to record